Patents, Lock-In and Negative Innovation
Patently-O
AUGUST 10, 2021
Feldman has also just published a short article in Nature Biotechnology titled Negative Innovation: When Patents are Bad for Patients. (Co-authored Nicholson Price (Michigan Law), David Hyman (Georgetown Law), and Mark Ratain (Chicago Med)). Generally the patent system has treated this is a FDA regulatory problem.
Let's personalize your content